Physician profile
Ruth M Barrow
NPI 1851428379
$3,125.43
in general payments reported to CMS, 2019-2025
25 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $458 · 2022: $538 · 2023: $1,121 · 2024: $738 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,036 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,035.63 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $520.17 | 2021-2024 | Qulipta, Lo Loestrin Fe, Ubrelvy |
| Mayne Pharma Commercial LLC | $486.13 | 2021-2025 | |
| Astellas Pharma US INC | $447.81 | 2021-2025 | Veozah |
| Daiichi Sankyo INC. | $327.15 | 2021-2023 | Injectafer |
| Evofem Biosciences, INC. | $181.61 | 2021-2023 | Phexxi |
| Sumitomo Pharma America, INC. | $175.90 | 2023-2025 | Myfembree |
| Pfizer INC. | $86.97 | 2021-2025 | |
| Myovant Sciences INC. | $85.52 | 2021-2022 | |
| Exact Sciences Corporation | $81.81 | 2023-2024 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $79.58 | 2022-2023 | Twirla |
| Biogen, INC. | $75.26 | 2024-2025 | Zurzuvae |
| Amgen INC. | $71.65 | 2021-2024 | Prolia, Evenity |
| Coopersurgical, INC. | $59.85 | 2021-2022 | |
| Hologic Sales and Service, LLC | $57.60 | 2023 | Acessa Provu System |
| Pacira Pharmaceuticals Incorporated | $51.70 | 2022-2024 | Exparel |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $49.84 | 2024 | |
| Heron Therapeutics, INC. | $45.63 | 2023 | Zynrelef |
| Therapeuticsmd, INC. | $38.76 | 2022 | |
| Medtronic, INC. | $38.10 | 2024 | Truclear |
| Novo Nordisk INC | $34.44 | 2023 | Wegovy |
| Scynexis, INC. | $31.11 | 2022 | |
| Avion Pharmaceuticals | $29.51 | 2021 | |
| Dexcom, INC. | $26.78 | 2025 | Dexcom G6 Transmitter |
| Bausch Health US, LLC | $21.77 | 2024 | Wellbutrin, Aplenzin |
| Exeltis, USA INC. | $20.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Barrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.